FABP2 and tuberculosis: At IRIS event or corresponding time point, I-FABP levels were significantly lower in TB-IRIS patients compared to controls (p = 0.013), and they remained so at month 3 (p = 0.049) and month 6 (p = 0.002) on treatment.